A handheld device for intra-cavity and ex vivo fluorescence imaging of breast conserving surgery margins with 5-aminolevulinic acid.
Christopher GibsonShirley C WangArcturus PhoonNayana Thalanki AnanthaKathryn Ottolino-PerryStephen PetropoulosZuha QureshiVasanth SubramanianAnam ShahidCristiana O'BrienSteven CarconeSuzanne ChungTeresa TsuiViktor SonMayleen SukhramFannong MengSusan J DoneAlexandra M EassonTulin CilMichael ReedijkWey L LeongRalph S DaCostaPublished in: BMC biomedical engineering (2024)
ClinicalTrials.gov Identifier: NCT01837225 (Trial start date is September 2010. It was registered to ClinicalTrials.gov retrospectively on April 23, 2013, then later updated on April 9, 2020, to reflect the introduction of the new imaging device.).
Keyphrases
- fluorescence imaging
- photodynamic therapy
- minimally invasive
- coronary artery bypass
- clinical trial
- study protocol
- high resolution
- phase iii
- phase ii
- surgical site infection
- neoadjuvant chemotherapy
- squamous cell carcinoma
- randomized controlled trial
- coronary artery disease
- open label
- mass spectrometry
- early breast cancer
- radiation therapy
- atrial fibrillation
- double blind